Quarterly report pursuant to Section 13 or 15(d)

Marketable Securities

v3.21.1
Marketable Securities
3 Months Ended
Mar. 31, 2021
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities
3.
Marketable Securities
Marketable securities at March 31, 2021 consisted of the following (in thousands):
 
Marketable Securities
  
Amortized Cost
    
Unrealized
Gains
    
Unrealized
Losses
    
Fair
 
Value
 
Current:
                                   
Corporate Debt
   $ 20,932      $ 1      $ (29 )    $ 20,904  
Long-term:
                                   
Corporate Debt
     1,031        —          (1      1,030  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total
   $ 21,963      $ 1      $ (30 )    $ 21,934  
    
 
 
    
 
 
    
 
 
    
 
 
 
Marketable securities at December 31, 2020 consisted of the following (in thousands):
 
Marketable Securities
  
Amortized Cost
    
Unrealized
Gains
    
Unrealized
Losses
    
Fair
 
Value
 
Current:
                                   
Corporate debt
   $ 27,026      $ 6      $ (27    $ 27,005  
Corporate debt includes obligations issued by investment-grade corporations, and may include issues that have been guaranteed by governments and government agencies. Investments classified as short-term have maturities of less than one year, and investments classified as long-term are those that have maturities of greater than one year and management does not intend to liquidate within the next twelve months. All of the Company’s marketable securities have an effective maturity of less than two years.
At March 31, 2021, the Company held 16 debt securities that individually and in total were in an immaterial unrealized loss position for less than one year. The aggregate fair value of debt securities in an unrealized loss position at March 31,
2021 was approximately 
$19.4
 million.
 
The Company evaluated its securities for other than temporary impairment and considered the decline in market value for the securities to be primarily attributable to current economic and market conditions. It was not more likely than not that the Company would have been required to sell the securities prior to the recovery of the amortized cost basis. Based on this analysis, these marketable securities were not considered to be other-than-temporarily impaired as of March 31, 2021.